National Jewish Health

National Jewish Health is known worldwide for treatment of patients with respiratory, cardiac, immune and related disorders, and for groundbreaking medical research. Located in Denver, CO, National Jewish Health is the leading respiratory hospital in the U.S. and has been ranked as the number one or two respiratory hospital all 17 years that specialty has been ranked by U.S. News & World Report.

National Jewish Health is a founding member of the Pulmonary Fibrosis Foundation Care Center Network, a group of medical centers with proven expertise in treating patients with fibrotic lung diseases.

National Jewish Health is the primary CT scan image analysis site for IPFnet, a clinical research network conducting clinical trials to evaluate treatments for patients with idiopathic pulmonary fibrosis.

The National Institutes of Health has designated and funded National Jewish Health as a Specialized Center of Research for Interstitial Lung Disease. Together with our basic scientists, the doctors and staff at National Jewish Health work to broaden understanding of the causes of interstitial lung diseases and develop new treatment approaches.

National Jewish Health has been accredited by the Accreditation Council for Continuing Medical Education (ACCME) since its inception in 1984. In December 2011, National Jewish Health received Accreditation with Commendation from the ACCME. This is the highest level of accreditation through the ACCME awarded to CME providers. National Jewish Health was commended not only for meeting the ACCME's Accreditation requirements, but also for demonstrating that the institution is a learning organization and a change agent for the physicians we serve.   Click here to learn more.